Novartis to Add Fourth US Radioligand Therapy Plant in Florida
Novartis will expand its US radioligand therapy manufacturing network with a new purpose-built facility in Winter Park, Florida, strengthening patient access across the southeastern US and supporting the company’s broader USD 23 billion investment in advanced manufacturing and oncology innovation.
RLT Medicines | 12/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy